Tag: TARGET BP

Ablative Solutions Announces Enrollment and Randomization of First Patient in Global Clinical Trial Evaluating Company’s Novel Therapy for Uncontrolled Hypertension

SAN JOSE, Calif., July 23, 2019 /PRNewswire/ — Ablative Solutions, Inc., a company pioneering new approaches to the treatment of hypertension, today announced the enrollment and randomization of the first patient in the TARGET BP I global clinical trial. Piedmont Heart Institute in Atlanta is the first hospital center worldwide to enroll and randomize […]